Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation.
Mehta J, Mehta J, Frankfurt O, Altman J, Evens A, Tallman M, Gordon L, Williams S, Winter J, Krishnamurthy J, Duffey S, Singh V, Meagher R, Grinblatt D, Kaminer L, Singhal S.
Mehta J, et al.
Leuk Lymphoma. 2009 Sep;50(9):1434-41. doi: 10.1080/10428190903085944.
Leuk Lymphoma. 2009.
PMID: 19603344